Israeli researchers reported in January that New York, NY-based AposTherapy’s biomechanical shoe-like device, which modulates center of pressure during walking, was associated with improved gait measures and quality of life (QOL) in a yearlong longitudinal study of patients with hip osteoarthritis.
Participants underwent gait analysis and reported on QOL measures in questionnaires.
They completed the assessments at baseline and after three, six, and 12 months. QOL measures improved, gait speed and cadence increased, and sagittal plane hip joint kinetics, kinematics, and spatiotemporal parameters improved compared with baseline.
The most substantial improvement occurred within three months of starting treatment, after which improvement approximately plateaued but was sustained at 12 months.
Speed and cadence, as well as several sagittal plane gait parameters, were significant predictors of QOL improvements.
The Journal of Orthopaedic Research epublished the study January 4.